ArticleInternational journal of dermatology2026
Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.
Joan Ceravalls et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.